http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2108662-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c6ce2c5c6a25193e28b0a4a976fdbae
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 1992-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9539c5ef1876e38156d507e5b4e85c9
publicationDate 1992-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2108662-A1
titleOfInvention Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders
abstract 2108662 9218129 PCTABS00160 The present invention relates to the use of a compound of general formula (I), in which R1, R2, R3, taken separately or in combination may represent a hydrogen atom, a hydroxyl radical, an acetoxy group CH3COO-, a group C1-C5 lower alkoxy or chain aklylenedioxy-O- (ch2) nO- in which n can take the values 1 or 2, and R4 can represent a hydrogen atom, an alkyl radical lower in C1-C5, or a phenyl ring optionally substituted by radicals or groups R1, R2, R3, of the same nature as those mentioned above, and R 'represents a hydrogen atom or a methyl radical, and its physiologically derived products acceptable for the manufacture of a medicament for the treatment of overactive or unstable bladders.
priorityDate 1991-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453965465
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID143334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411995342
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID143334

Total number of triples: 28.